About Evergreen

Real medicine, not hype.

Evergreen Telehealth is a direct-to-consumer telehealth platform connecting people with licensed clinicians and physician-guided health programs — built on real medicine, not hype.

We're LegitScript Certified. Every program is designed by licensed clinicians, and every medication is sourced through pharmacies held to U.S. pharmaceutical standards for human use.

What We Do

Evergreen offers physician-guided programs across weight management, recovery, and long-term health. Our first programs launch September 2026.

Evergreen Lean

Coming Soon

A physician-guided weight management program.

Evergreen Recovery

Coming Soon

A physician-guided recovery program.

Hormone Health

Coming Soon

Physician-guided hormone support programs.

Longevity

Coming Soon

Programs designed for long-term healthspan.

More detail on each program will be added as they launch.

Why Evergreen

LegitScript Certified

Held to a recognized standard for safety, legitimacy, and transparency in online healthcare.

Licensed Clinicians

Licensed clinicians oversee every program from intake through follow-up.

U.S. Sterile-Compliant Pharmacies

Medications are sourced through U.S.-based pharmacies built for human use.

Straight Answers, No Hype

We tell you what's real — grounded in evidence and clinical oversight.

Clinical Oversight

Dr. Casey Greene, PharmD, FMCP

Your guide to peptide science

Dr. Casey Greene, PharmD, FMCP

Senior Director of Clinical Informatics

PharmDFMCP — Functional Medicine Certified PractitionerIFM Certified PractitionerA4M Peptide Certified

Dr. Greene is one of a select few pharmacists in the country to hold A4M Peptide Therapy Certification. He leads Evergreen's internal peptide training program — ensuring every clinician on our team meets the highest clinical standards before a single protocol reaches a patient. His work centers on translating current peptide science into rigorous, prescriber-ready clinical education built for depth over surface-level summaries.

“The difference between a well-formulated peptide protocol and a risky one isn't just the molecule. It's the compounding standards, the clinical oversight, and the education behind every decision.”

Be first when we open.

Memberships open September 2026. Join the waitlist for early access.

Last reviewed: July 26, 2026